"first author
(year)","Baseline disease cohort 
[a=autoimmunity, m=malignancy, t=transplant]",study specific case/patient ID number,"sex
[male, female]",age,baseline disease,baseline therapy,"Vaccination 
[yes / no] (doses)","Hospitalization
[yes / no]",SARS-CoV-2 genotype,"CT lung changes?
[yes / no]","SARS-CoV-2 replication
[days]","any glucocorticosteroid usage
[yes / no]","1st line treatment any other antiviral drugs 
(days) [dosage]","1st line standard or prolonged NMV-r treatment
[yes / no]","1st line NMV-r standard duration treatment courses 
(n)","2nd line treatment form of therapy 
[m / c]
mono: only NMV-r
combination: NMV-r + any other antiviral drugs","2nd line extended NMV-r treatment 
(total days) [courses]","2nd line any other concomitant antiviral therapy 
(days)  [dosages]","any adverse events
[yes / no]",type of adverse event,"eradication outcome successful
[yes / no]","survival outcome
[yes / no]"
"Antonello
(2024)",m,1,m,73,FL,RTX + lenalidomide,y (4),n/a,BA.5.2.23,y,64,n,TIX-CIL [1],y,1,c,10 [1],MPV (10),n,n,y,y
"Antonello
(2024)",m,2,f,55,NHL,RTX,y (3),n/a,n/a,y,218,n,none,y,1,c,10 [1],MPV (10),n,n,y,y
"Antonello
(2024)",m,3,m,66,MCL,RTX + BEN + cytarabine,y (3),n/a,n/a,n,26,n,MPV (5) → SOT [1],n,0,c,10 [1],MPV (10),n,n,y,y
"Antonello
(2024)",m,5,m,76,FL,RTX,y (5),n/a,BF.7,y,20,n,RDV (7),n,0,c,10 [1],RDV (10) + SOT [1],n,n,y,y
"Antonello
(2024)",m,6,m,61,NHL,RTX,y (4),n/a,BQ.1.5,y,102,n,none,y,1,c,10 [1],MPV (10),n,n,y,y
"Antonello
(2024)",m,7,f,66,FL,none,y (3),n/a,BA.5.2.1,y,169,n,TIX-CIL [1],n,0,c,7 [1],RDV (10) + MPV (10),y,"nausea, dysgeusia",y,y
"Antonello
(2024)",m,8,m,68,AML,ASCT →MMF + steroids*,y (5),n/a,XAY.1.1,y,38,y*,MPV (15) → SOT [1],n,0,c,10 [1],RDV (10),n,n,y,y
"Antonello
(2024)",m,9,f,71,"CLL, FL",Pirtobrutinib + steroids*,y (3),n/a,BF.1,y,272,y*,MPV (38),y,1,c,10 [1],RDV (10) + SOT [1],y,dysgeusia,y,n
"Barone
(2024)",m,3,f,76,DLBCL,R-COMP,y (4),n/a,EG.5.1,n/a,24,n,none,n,0,c,6 [1],RDV (5),n,n,y,y
"Barone
(2024)",m,4,m,85,CLL,PDN*,y (2),n/a,XCH.1,n/a,27,y*,none,n,0,c,14 [1],RDV (14),n,n,y,y
"Barone
(2024)",m,6,f,73,DLBCL,RTX + polatuzumab + BEN,y (3),n/a,XBF,n/a,78,n,SOT [1],n,0,c,9 [1],RDV (1),n,n,y,y
"Breeden
(2023)",m,2,m,72,DLBCL,CAR-T,y (2),y,n/a,y,46,n,TIX-CIL [1],y,1,c,20 [1],RDV (10),n,n,y,y
"De Benedetto
(2024)",m,2,f,81,DLBCL,RTX + chlorambucil,y (5),y,n/a,y,31,y,none,n,0,c,10 [1],RDV (10),n,n,y,y
"De Benedetto
(2024)",m,3,m,63,CLL,FCR,y (3),y,n/a,y,29,y,RDV (5),n,0,c,10 [1],RDV (10),n,n,y,y
"De Benedetto
(2024)",m,4,m,66,FL,R-CHOP,y (3),y,n/a,y,21,y,RDV (5),n,0,c,10 [1],RDV (10),n,n,y,y
"Dentone
(2023)",m,n/a,m,80,"CLL, FL",RTX + BEN,y (4),y,CH.1.1,y,36,y,none,n,0,c,20 [2],TIX-CIL [1] → RDV (10) → RDV (10) → MPV (10),n,n,y,y
"Faxen
(2023)",a,1,f,25,MCTD,RTX + PDN*,y (3),n,BA.2,y,183,y*,none,n,0,c,10 [1],TIX-CIL [2],n,n,y,y
"Faxen
(2023)",m,3,m,76,FL,RTX + lenalidomide + epcoritamab,y (4),n,BA.2,n/a,242,n,TIX-CIL [3] → RDV (5),y,2,c,10 [1],RDV (10),n,n,y,y
"Ford
(2023)",m,1,m,40,B-ALL,RTX + hyper-CVAD,n/a,y,BA.1.1,y,152,y,CAS-IMD [1] → SOT [1] → RDV (10),n,0,c,20 [2],SOT [1],y,abdominal bloating,y,y
"Gai
(2024)",m,1,m,57,MALT,CD-20 mAb*,n/a,n/a,BF.7.14,y,122,y,none,y,1,c,10 [1],TIX-CIL [1],n,n,y,y
"Götz
(2023)",m,FR_4,m,82,Follicular lymphoma,RTX,y (8),y,n/a,y,44,none,none,n,0,c,24 (1),RDV 5 (1),n,n,y,y
"Götz
(2023)",m,FR_5,m,70,Follicular lymphoma,RTX,y (4),y,BA5.6,y,104,DXA,MPV (5) + RDV (5) + RDV (5) + RDV (10),n,0,c,21,MPV 39 (1),n,n,n,y
"Götz
(2023)",m,FR_6,f,71,Mantle cell lymphoma,RTX,y (5),y,BF.7,y,61,DXA,none,n,0,c,61 (1),MPV 28 (1) + RDV 21 (1),n,n,y,y
"Götz
(2023)",m,FR_7,f,43,Plasma cell maturing marginal zone B-cell lymphoma of the skin,RTX,n,y,n/a,y,152,DXA,none,n,0,c,34 (1),MPV 34 (1),n,n,y,y
"Götz
(2023)","t, a",FR_9,f,67,Kidney-TX + Colitis ulcerosa,TAC + MMF + PDN,y (4),y,n/a,y,73,none,none,n,0,c,5(1),MPV 5 (directly afterwards),y,Supratherapeutic TAC,n,y
"Hirotsu
(2023)",m,n/a,m,65,Malignant Lymphoma,RTX,y (2),y,BA.1.1.2,y,216,y,SOT [6] → RDV (35) [4] → MPV [4] → IVIg [7],y,3,c,19 [2],SOT [6],n,n,n,n
"Longo
(2023)",m,#4,n/a,65,DLBCL,R-CHOP → CAR-T  → GEMOX +  epcoritimab → R-MAGRATH,yes (≥2),n/a,n/a,n/a,96,n,RDV (10) → TIX-CIL [1],y,1,c,20 [1],RDV (10),n,n,y,n
"Longo
(2023)",m,#8,n/a,73,FL,OBI,yes (≥2),n/a,n/a,n/a,71,n,RDV (10) → TIX-CIL [1],y,1,c,10 [1],RDV (10),n,n,y,y
"Marangoni
(2023)",m,n/a,m,73,FL,RTX + chlorambucil  → RTX + BEN  → RTX + lenalidomide,n/a,y,BA.5.2.23,y,69,y,TIX-CIL [1],y,1,c,10 [1],MPV (10),n,n,y,y
"Maruyama
(2024)",m,3,f,81,FL,GB  → Rm,y (3),n/a,BA.1.1,n/a,104,y,SOT [1] → CAS-IMD [1] → RDV (7),y,1,c,8 [1],RDV (8),n,n,y,y
"Maruyama
(2024)",m,6,f,79,FL,R-CHOP  → RB  → GB  → Gm,y (3),n/a,BA.1.1.1,n/a,98,n,SOT [1] → CAS-IMD [1] → RDV (7),y,1,c,8 [1],RDV (8),n,n,y,y
"Maruyama
(2024)",m,12,f,80,DLBCL,R-CHOP  → Pola-BR,y (2),n/a,BA.5.1,n/a,40,n,CAS-IMD [1] → MPV (10),y,1,c,10 [1],MPV (10),n,n,y,y
"Maruyama
(2024)",m,13,m,76,FL,R-CHOP  → GB  → Gm,y (3),n/a,BA.5.2.20,n/a,27,n,CAS-IMD [1],n,0,c,10 [1],MPV (10),n,n,y,y
"Maruyama
(2024)",m,17,m,54,FL,R-CHOP  → RB  → Rm  → GB  → Gm,y (3),n/a,BA.5.2.1,n/a,76,y,CAS-IMD [1] → MPV (5) → RDV (8),n,0,c,10 [1],RDV (10),n,n,y,y
"Maruyama
(2024)",m,18,m,81,FL,R  → GB → Gm,y (3),n/a,BA.5.1,n/a,92,y,CAS-IMD [1] → TIX-CIL [1] → RDV (30),y,1,c,15 [1],MPV (15),n,n,y,y
"Maruyama
(2024)",m,33,m,66,MCL,R-CHOP/R-DHAP  → IBR  → RB,y (5),n/a,FR.1,n/a,57,y,SOT [1] → CAS-IMD [1] → TIX-CIL [1] → MPV (10) → ENS (5) → RDV (5) → ENS (10),y,1,c,15 [1],MPV (15),n,n,n,y
"Pasquini
(2023)",m,#1,m,46,FL,OBI + zanobrutinib,yes (n/a),y,n/a,y,144,n,none,y,1,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#2,m,58,FL,Mosunetuzumab,yes (n/a),y,n/a,y,33,n,none,y,1,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#3,f,57,FL,OBI,yes (n/a),y,n/a,n,45,n,none,y,1,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#4,m,54,Indolent NHL,RTX + BEN,yes (n/a),y,n/a,y,43,n,none,y,1,c,13 [1],RDV (13),n,n,y,y
"Pasquini
(2023)",m,#5,m,63,FL,OBI + CHOP,yes (n/a),y,n/a,y,42,y*,MPV (5 days),n,0,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#6,m,35,DLBCL,RTX + BFM + DHAP,yes (n/a),y,n/a,n,35,y*,none,y,1,c,22 [1],RDV (22),n,n,y,y
"Pasquini
(2023)",m,#7,m,84,MCL,RTX + BEN,yes (n/a),y,n/a,y,48,n,none,n,0,c,10 [1],RDV [10],n,n,y,y
"Pasquini
(2023)",m,#8,m,69,DLBCL,OBI + glofitamab + polatuzumab,yes (n/a),y,n/a,y,116,n,SOT [1],n,0,c,10 [1],RDV [10],n,n,y,y
"Pasquini
(2023)",m,#9,m,59,DLBCL,CAR-T,yes (n/a),y,n/a,y,46,n,none,y,1,c,12 [1],RDV (12),n,n,y,y
"Pasquini
(2023)",a,#10,m,56,MS,Ocrelizumab,yes (n/a),y,n/a,y,21,n,none,n,0,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#11,f,89,DLBCL,RTX + CHOP,yes (n/a),y,n/a,n,42,y*,none,n,0,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#12,f,71,CLL,none,yes (n/a),y,n/a,n,30,n,none,n,0,c,10 [1],RDV (10),n,n,y,y
"Pasquini
(2023)",m,#14,m,61,DLBCL,CAR-T,yes (n/a),y,n/a,n/a,35,n,none,n,0,c,10 [1],RDV (10),n,n,y,y
"Sanmartin
(2024)",m,n/a,m,67,CLL,IBR,y (4),y,BA.5.1,y,215,y,RDV (5) → TIX-CIL [1] → RDV (5) → RDV (5) → covalescent plasma [1],y,1,c,10 [1],RDV (10),n,n,n,n
"Snell
(2024)",m,OLOL-001,f,50,Hematological malignancy ,OBI,y (6),y,BQ.1.1.2 ,y,72,y,RDV (5) → RDV (5),n,0,c,10 [1],RDV (5),y,thrombocytopenia,y,y
"Snell
(2024)",a,BMT-002,f,48,NMDA-receptor encephalitis,RTX,y (4),y,n/a,y,76,y,RDV (25) → SOT [1],n,0,c,18 [1],IvIg,n,n,y,y
"Snell
(2024)",m,GSTT-005,f,77,Haematological malignancy,RTX  → OBI,y (5),y,BQ.1.1,y,76,y,RDV (10),n,0,c,10 [1],SOT [1],n,n,n/a,y
"Snell
(2024)",m,GSTT-004,f,77,Haematological malignancy,OBI,y (5),n,BQ.1.1,y,203,n,none,n,0,c,10 [1],SOT [1],n,n,y,y
"Snell
(2024)",m,GSTT-003,f,77,Haematological malignancy,RTX,y (4),y,BQ.1.1.3,y,101,y,RDV (10),n,0,c,10 [1],RDV (1) + SOT [1],n,n,y,y
"Snell
(2024)",m,GSTT-001,m,61,Haematological malignancy,RTX  → OBI,y (4),y,BA.2.3,y,137,y,RDV (10) → RDV (5) → SOT [1],y,1,c,10 [1],RDV (10),n,n,y,y
"Trottier
(2023)",m,n/a,m,64,CLL,Venetoclax + OBI,y (3),y,n/a,y,120,y,RDV (10) → BEB [1],y,1,c,20 [1],RDV (20),n,n,y,y